Search

everythinglearnresearchcommunity

for

Search:↓

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

QR678 and QR678 Neo treatments, combined with corticosteroid injections, work better for alopecia areata than corticosteroid injections alone.

Natural products and phytochemicals may help with hair regrowth, but more research is needed.

People with alopecia areata in German-speaking countries spend a lot on their condition, with hair products and treatments being the most costly.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

The minoxidil gel could be a better treatment for hair loss than traditional forms.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Platelet-rich plasma therapy is a safe and effective treatment for alopecia areata.

Plum-blossom needling with conventional treatments improves hair regrowth in alopecia areata.

PRP treatment reduces inflammation and increases interleukin-10 in alopecia areata patients.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Tinea capitis is increasingly common in elderly women and requires accurate diagnosis with fungal cultures for effective treatment.

Microneedling with betamethasone led to almost complete hair regrowth in severe alopecia areata.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Manipulating cell cleanup processes could help treat hair loss.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Alopecia totalis/universalis is a severe form of hair loss where all body hair is lost.

People in palliative care often have skin problems due to their main illness or other health issues, and treatments focus on comfort and quality of life.

Early recognition and treatment of tinea capitis are crucial to prevent severe scalp issues and prolonged therapy.

Alopecia areata has a high chance of persisting and relapsing, with a significant risk of total hair loss, especially if it starts in childhood.

Treating stubborn hair loss involves both medical and emotional support options.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

In Poland, people search more for certain skin conditions depending on the season, and despite more STD infections, searches for them have decreased, suggesting a need for better sexual education.

Iron deficiency without anemia can cause itching and other skin-related symptoms, and iron supplements may help.

Alopecia areata can be transferred through stem cell transplants from affected siblings.

Ibuprofen, menthol, and cetirizine may help prevent or slow hair loss.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

Practitioners treating hair loss need better education and resources to overcome challenges like commercial bias and ethical dilemmas.

Clobetasol propionate, 0.05%, is more effective and safe for treating childhood alopecia areata than hydrocortisone, 1%.